Scott Weingarten, MD, MPH, is Chief Executive Officer of Stanson Health, recently acquired by Premier, Inc, consultant to the CEO at Cedars-Sinai, and Professor of Medicine at Cedars-Sinai. Stanson Health is a clinical decision support, artificial intelligence, and analytics company which has been purchased by approximately 450 hospitals and is used by more than 125,000 providers. He is also a Health Sciences Clinical Professor of Medicine (Level 5) at the David Geffen School of Medicine at UCLA. He had reached Full Professor (In Residence) at the David Geffen School of Medicine at UCLA before he switched to the Clinical Series to start medical informatics businesses.
Board certified in internal medicine and a fellow of the American College of Physicians, Dr. Weingarten has published approximately 100 articles and editorials on healthcare quality improvement, clinical decision support, and related topics, and has authored numerous chapters on improving the quality of patient care in some of the leading internal medicine textbooks. He has given more than 300 presentations on clinical decision support and related topics throughout the United States and internationally. He is a New England Journal of Medicine Catalyst “Thought Leader.”
Dr. Weingarten has held positions on myriad national committees dedicated to improving patient outcomes, including the National Academy of Medicine Committee on Clinical Decision Support, the American Heart Association’s “Get With The Guidelines” program, and the quality improvement committee of the board of directors of St. Joseph’s Health System. He is currently a Board of Director for the Scottsdale Institute. At Cedars-Sinai, he has received the President’s Award, the Golden Apple Teaching Award, and Alumnus of the Year.
Dr. Weingarten was the co-founder, president and chief executive officer of Zynx Health, which was the leader for order sets and care plans for electronic health records. Scott sold Zynx Health to the Cerner Corporation and later to the Hearst Corporation. During Scott’s tenure as CEO, Zynx Health was one of the Hearst Corporation’s larger companies. He is a co-inventor of three software patents granted by the United States Patent and Trademark Office. He later sold Stanson Health to Premier, Inc., leading to two successful “exits.”
After graduating from UCLA’s medical school, Dr. Weingarten completed his internship, residency and fellowship in internal medicine at Cedars-Sinai. He later participated in a National Center for Health Services Research Fellowship at the RAND/UCLA Center for Health Policy Study. During the fellowship, he also earned a Master’s of Public Health degree at the UCLA Fielding School of Public Health.
Dr. Weingarten has also worked as a primary care physician at Kaiser Permanente and was awarded partnership status at Southern California Permanente Medical Group. He helped launch and lead Kaiser Permanente Woodland Hills Ambulatory Quality Improvement program.
Stanson Health 2013-2019
Scott co-founded a successful clinical decision support and analytics company which produced software to improve the value of patient care across the continuum and to automate the medical necessity portion of prior authorization. As CEO and Chairman of the Board, the company developed Natural Language Process, Machine Learning, and Artificial Intelligence capabilities. Under Scott’s leadership, Stanson grew from a start-up to having greater than 125,000 provider and 450 hospital customers. The company has been rated number one by KLAS for Clinical Process Improvement software. Scott sold to Premier in 2018 with a very good return on investment for investors, including Cedars-Sinai, and shareholders.
Scott served as Senior Vice President and Chief Clinical Transformation Officer and led initiatives to improve value of care across the health system, including Cedars-Sinai Medical Center and the Cedars-Sinai Medical Network. According to Integrated Healthcare Association, during Scott’s tenure Cedars-Sinai Medical Group and Cedars-Sinai IPA achieved some of the greatest improvements in total cost of care among physician organizations in California while maintaining high quality scores. Cedars-Sinai’s Anthem’s ACO had the highest reduction in total cost among any Anthem ACO, and also achieved high quality scores. According to Vizient’s Clinical Data Base, during Scott’s tenure Cedars-Sinai had the highest one-year reduction in severity-adjusted length of stay for medicine and surgery of any academic health system in the United States, with high quality scores. IBM named Cedars as one of the Top 100 hospitals in the United States, which reflected significant improvements in the value of care.
Zynx Health 1996-2012
Scott co-founded Zynx Health and served as President and Chief Executive Officer for 16 years. Zynx was the first evidence-based order set company. During Scott’s leadership, Zynx progressed from early start-up to become the market leader with more than 2,000 hospital customers in the United States, hospitals who cared for about 55% of all hospitalized patients, and a global client base. During the 16 years of his tenure as CEO, Zynx’s value increased more than 1,000-fold from the initial total investment. He led Zynx through a sale to Cerner and later to the Hearst Corporation with excellent “return on investments” for shareholders.
Updated December 2019